Sensei Biotherapeutics Statistics
Total Valuation
SNSE has a market cap or net worth of $10.18 million. The enterprise value is -$24.71 million.
Important Dates
The last earnings date was Friday, March 28, 2025, before market open.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SNSE has 25.15 million shares outstanding. The number of shares has decreased by -10.14% in one year.
Current Share Class | 25.15M |
Shares Outstanding | 25.15M |
Shares Change (YoY) | -10.14% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | 2.23% |
Owned by Institutions (%) | 9.40% |
Float | 16.52M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.33 |
P/TBV Ratio | 0.33 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.70, with a Debt / Equity ratio of 0.10.
Current Ratio | 7.70 |
Quick Ratio | 7.59 |
Debt / Equity | 0.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -351.81 |
Financial Efficiency
Return on equity (ROE) is -58.40% and return on invested capital (ROIC) is -34.92%.
Return on Equity (ROE) | -58.40% |
Return on Assets (ROA) | -33.06% |
Return on Invested Capital (ROIC) | -34.92% |
Return on Capital Employed (ROCE) | -79.33% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.08M |
Employee Count | 28 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.90% in the last 52 weeks. The beta is 0.15, so SNSE's price volatility has been lower than the market average.
Beta (5Y) | 0.15 |
52-Week Price Change | -61.90% |
50-Day Moving Average | 0.47 |
200-Day Moving Average | 0.54 |
Relative Strength Index (RSI) | 41.28 |
Average Volume (20 Days) | 8,071,800 |
Short Selling Information
The latest short interest is 121,029, so 0.48% of the outstanding shares have been sold short.
Short Interest | 121,029 |
Short Previous Month | 146,655 |
Short % of Shares Out | 0.48% |
Short % of Float | 0.73% |
Short Ratio (days to cover) | 1.42 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -31.66M |
Pretax Income | -29.67M |
Net Income | -30.16M |
EBITDA | -30.34M |
EBIT | -31.66M |
Earnings Per Share (EPS) | -$1.20 |
Full Income Statement Balance Sheet
The company has $41.34 million in cash and $3.85 million in debt, giving a net cash position of $37.49 million or $1.49 per share.
Cash & Cash Equivalents | 41.34M |
Total Debt | 3.85M |
Net Cash | 37.49M |
Net Cash Per Share | $1.49 |
Equity (Book Value) | 38.39M |
Book Value Per Share | 1.52 |
Working Capital | 36.48M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$24.67 million and capital expenditures -$146,000, giving a free cash flow of -$24.82 million.
Operating Cash Flow | -24.67M |
Capital Expenditures | -146,000 |
Free Cash Flow | -24.82M |
FCF Per Share | -$0.99 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |